-
Je něco špatně v tomto záznamu ?
Poly-N-Acetyllactosamine Neo-Glycoproteins as Nanomolar Ligands of Human Galectin-3: Binding Kinetics and Modeling
L. Bumba, D. Laaf, V. Spiwok, L. Elling, V. Křen, P. Bojarová,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Free Medical Journals
od 2000
Freely Accessible Science Journals
od 2000
PubMed Central
od 2007
Europe PubMed Central
od 2007
ProQuest Central
od 2000-03-01
Open Access Digital Library
od 2000-01-01
Open Access Digital Library
od 2007-01-01
Health & Medicine (ProQuest)
od 2000-03-01
ROAD: Directory of Open Access Scholarly Resources
od 2000
PubMed
29373511
DOI
10.3390/ijms19020372
Knihovny.cz E-zdroje
- MeSH
- galektin 3 chemie metabolismus MeSH
- glykoproteiny chemie farmakologie MeSH
- laktosa analogy a deriváty chemie MeSH
- lidé MeSH
- ligandy MeSH
- sérový albumin hovězí chemie MeSH
- simulace molekulového dockingu * MeSH
- vazba proteinů MeSH
- vazebná místa MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Galectin-3 (Gal-3) is recognized as a prognostic marker in several cancer types. Its involvement in tumor development and proliferation makes this lectin a promising target for early cancer diagnosis and anti-cancer therapies. Gal-3 recognizes poly-N-acetyllactosamine (LacNAc)-based carbohydrate motifs of glycoproteins and glycolipids with a high specificity for internal LacNAc epitopes. This study analyzes the mode and kinetics of binding of Gal-3 to a series of multivalent neo-glycoproteins presenting complex poly-LacNAc-based oligosaccharide ligands on a scaffold of bovine serum albumin. These neo-glycoproteins rank among the strongest Gal-3 ligands reported, with Kd reaching sub-nanomolar values as determined by surface plasmon resonance. Significant differences in the binding kinetics were observed within the ligand series, showing the tetrasaccharide capped with N,N'-diacetyllactosamine (LacdiNAc) as the strongest ligand of Gal-3 in this study. A molecular model of the Gal-3 carbohydrate recognition domain with docked oligosaccharide ligands is presented that shows the relations in the binding site at the molecular level. The neo-glycoproteins presented herein may be applied for selective recognition of Gal-3 both on the cell surface and in blood serum.
Institute of Microbiology of the Czech Academy of Sciences Vídeňská 1083 14220 Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18033362
- 003
- CZ-PrNML
- 005
- 20181010124903.0
- 007
- ta
- 008
- 181008s2018 sz f 000 00|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ijms19020372 $2 doi
- 035 __
- $a (PubMed)29373511
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Bumba, Ladislav $u Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, 14220 Prague, Czech Republic. bumba@biomed.cas.cz.
- 245 10
- $a Poly-N-Acetyllactosamine Neo-Glycoproteins as Nanomolar Ligands of Human Galectin-3: Binding Kinetics and Modeling / $c L. Bumba, D. Laaf, V. Spiwok, L. Elling, V. Křen, P. Bojarová,
- 520 9_
- $a Galectin-3 (Gal-3) is recognized as a prognostic marker in several cancer types. Its involvement in tumor development and proliferation makes this lectin a promising target for early cancer diagnosis and anti-cancer therapies. Gal-3 recognizes poly-N-acetyllactosamine (LacNAc)-based carbohydrate motifs of glycoproteins and glycolipids with a high specificity for internal LacNAc epitopes. This study analyzes the mode and kinetics of binding of Gal-3 to a series of multivalent neo-glycoproteins presenting complex poly-LacNAc-based oligosaccharide ligands on a scaffold of bovine serum albumin. These neo-glycoproteins rank among the strongest Gal-3 ligands reported, with Kd reaching sub-nanomolar values as determined by surface plasmon resonance. Significant differences in the binding kinetics were observed within the ligand series, showing the tetrasaccharide capped with N,N'-diacetyllactosamine (LacdiNAc) as the strongest ligand of Gal-3 in this study. A molecular model of the Gal-3 carbohydrate recognition domain with docked oligosaccharide ligands is presented that shows the relations in the binding site at the molecular level. The neo-glycoproteins presented herein may be applied for selective recognition of Gal-3 both on the cell surface and in blood serum.
- 650 _2
- $a vazebná místa $7 D001665
- 650 _2
- $a galektin 3 $x chemie $x metabolismus $7 D037502
- 650 _2
- $a glykoproteiny $x chemie $x farmakologie $7 D006023
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a laktosa $x analogy a deriváty $x chemie $7 D007785
- 650 _2
- $a ligandy $7 D008024
- 650 12
- $a simulace molekulového dockingu $7 D062105
- 650 _2
- $a vazba proteinů $7 D011485
- 650 _2
- $a sérový albumin hovězí $x chemie $7 D012710
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Laaf, Dominic $u Laboratory for Biomaterials, Institute for Biotechnology and Helmholtz-Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 20, 52074 Aachen, Germany. d.laaf@biotec.rwth-aachen.de.
- 700 1_
- $a Spiwok, Vojtěch $u Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, Technická 3, 16628 Prague 6, Czech Republic. Vojtech.Spiwok@vscht.cz.
- 700 1_
- $a Elling, Lothar $u Laboratory for Biomaterials, Institute for Biotechnology and Helmholtz-Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 20, 52074 Aachen, Germany. l.elling@biotec.rwth-aachen.de.
- 700 1_
- $a Křen, Vladimír $u Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, 14220 Prague, Czech Republic. kren@biomed.cas.cz.
- 700 1_
- $a Bojarová, Pavla $u Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, 14220 Prague, Czech Republic. bojarova@biomed.cas.cz.
- 773 0_
- $w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 19, č. 2 (2018)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29373511 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20181008 $b ABA008
- 991 __
- $a 20181010125352 $b ABA008
- 999 __
- $a ok $b bmc $g 1340888 $s 1030356
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 19 $c 2 $e 20180126 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
- LZP __
- $a Pubmed-20181008